UBX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 18:48):

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging...

Stats
Dagens volum	27 694.00
Gjennomsnittsvolum	90 258.00
Markedsverdi	25.43M
EPS	$0 ( 2024-04-03 )
Neste inntjeningsdato	( $-0.570 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.560
ATR14	$0.00500 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-26	Nguyen Alexander Hieu	Buy	30 000	Stock Option (Right to Buy)
2024-03-26	Nguyen Alexander Hieu	Buy	20 000	Common Stock, $0.0001 par value
2024-02-02	Ghosh Anirvan	Sell	680	Common Stock, $0.0001 par value
2024-01-30	Ghosh Anirvan	Sell	1 183	Common Stock, $0.0001 par value
2023-11-02	Ghosh Anirvan	Sell	589	Common Stock, $0.0001 par value

INSIDER POWER
55.05
Last 99 transactions
Buy: 2 792 498 \| Sell: 401 244

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: 1.00 (very strong)

Signal:(50.941) Expect same movement, but be aware

UNITY Biotechnology Inc Korrelasjon

10 Mest positive korrelasjoner
XLRN	0.938
BRACU	0.938
NVCN	0.934
LX	0.931
ATRS	0.924
SY	0.924
ATCX	0.923
PUCK	0.919
GXII	0.919
OVID	0.918

10 Mest negative korrelasjoner
NAKD	-0.928
AHPI	-0.923
AMGN	-0.908
PROC	-0.906
GRPH	-0.905
GRIN	-0.903
LCAP	-0.899
LAWS	-0.896
TRIT	-0.892
CYTO	-0.888

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

UNITY Biotechnology Inc Korrelasjon - Valuta/Råvare

0.83
( strong )

0.80
( strong )

0.00
( neutral )

-0.75
( moderate negative )

-0.79
( moderate negative )

UNITY Biotechnology Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1.18M (0.00 %)
EPS:	$-2.70

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1.18M (0.00 %)
EPS:	$-2.70

FY	2022
Omsetning:	$236 000
Bruttogevinst:	$-1.94M (-823.73 %)
EPS:	$-6.08

FY	2021
Omsetning:	$4 784.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.0109

Financial Reports:

No articles found.

UNITY Biotechnology Inc

Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.